CL
BIVV

CIM LLC’s Bioverativ Inc. Common Stock BIVV Stock Holding History

CIM LLC’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,360
Closed -$397K – 103
2017
Q4 		$397K Sell
7,360
-12,874
-64% -$704K 0.16% 76
2017
Q3 		$1.16M Sell
20,234
-792
-4% -$46.4K 0.48% 26
2017
Q2 		$1.26M Sell
21,026
-2,213
-10% -$126K 0.54% 24
2017
Q1 		$1.26M Buy
+23,239
New +$1.14M 0.57% 24

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

CIM LLC's BIVV Position: Q1 2018 in Review

CIM LLC sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,360 shares — an estimated $397K sold.

CIM LLC first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.26M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • CIM LLC reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • CIM LLC sold 7,360 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $397K.
  • CIM LLC first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • CIM LLC's Bioverativ Inc. Common Stock position peaked at $1.26M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on CIM LLC's 13F filing for Q1 2018, filed 5 Apr 2018.